LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Levamisole induced toxic epidermal necrolysis: A case report

Photo from wikipedia

Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life‐threatening immune‐mediated hypersensitivity reactions. Various drugs, such as Non Steroidal Anti‐inflammatory drugs (NSAIDS), allopurinol, anticonvulsants and antibiotics, have been implicated as… Click to show full abstract

Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life‐threatening immune‐mediated hypersensitivity reactions. Various drugs, such as Non Steroidal Anti‐inflammatory drugs (NSAIDS), allopurinol, anticonvulsants and antibiotics, have been implicated as triggering agent of SJS/TEN. Levamisole is frequently used as an antihelminthic and as an immunomodulator in cases of nephrotic syndrome. However, levamisole has not been reported as a trigger for SJS/TEN. The current case describes levamisole‐induced TEN in a 15‐year‐old male who presented to emergency with erythematous lesions, blistering and denudation of skin involving up to 30% of body surface area. Algorithm of drug causality for epidermal necrolysis scoring was applied for causality assessment and a relationship was found to be “possible”. Immediate withdrawal of levamisole along with a short course of corticosteroids and cyclosporine led to improvement in signs and symptoms. Clinicians should be aware of the possible association of levamisole and SJS/TEN.

Keywords: levamisole; sjs; epidermal necrolysis; levamisole induced; toxic epidermal

Journal Title: British Journal of Clinical Pharmacology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.